FEATURED EDITORIAL
New research concludes that potency cannot be decoupled from a product's mechanism of action because surrogate markers fail to capture functional relevance.
- How To Approach Tech Transfers And Sponsored Life Sciences Research In An AI Age
- Applying AI To Identify Synergistic Drug Combinations For Cancer Treatment
- Mesenchymal Stem Cells Hold The Key To Treating Degenerative Conditions
- Understanding The New U.K. MHRA 'Draft Guideline On Individualised mRNA Cancer Immunotherapies'
- Drug Design At The Speed Of Quantum
- EMA Issues Paper On Qualifying Non-Mutagenic Impurities For Drug Toxicological Safety
- 9 Reasons Why You Should Consider AI In Analytical Instrument Qualification
FEATURED APPLICATION CONTENT
-
Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.
-
Overcoming the limitations of current proximity inducers requires optimizing cooperativity. Learn how enhancing target affinity can lead to smaller, more effective therapeutics with better safety profiles.
-
Maximize your research potential by overcoming workflow bottlenecks. This piece explores flexible strategies for increasing throughput and integrating automation seamlessly into your laboratory operations.
-
Continuous processes enhance product quality, yield, and cost savings. Explore transitioning a fed-batch process to perfusion using a small batch bioreactor system to optimize cell culture conditions and comparing performances.
-
Discover how a company overcame cell generation challenges by using a system that achieves a seed ratio of 1:120 and saves four days in seed preparation time.
-
Efforts to enhance biopharmaceutical manufacturing focus on boosting production capacity sustainably and economically. Explore how optimizing processes with single-use solutions and monitoring leachables ensures product quality.
-
Discover the critical role of formulation buffer composition in stabilizing monoclonal antibodies during tangential flow filtration, a process involving ultrafiltration and diafiltration under high pressure and shear forces.
-
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
Explore how tangential flow filtration (TFF) systems streamline lentivirus purification to enhance efficiency and scalability in CAR-T cell production, which is a crucial advancement in cancer immunotherapy.
-
Stem cell research has revolutionized tissue repair and regenerative medicine. Discover how mesenchymal stem cells play a key role and offer insights into connective tissue repair, immune response, and inflammatory diseases.
-
Discover how transitioning from 2D to 3D culture methods enhances the scalability, yield, and quality of Mesenchymal Stem Cells (MSCs) for therapeutic applications to address critical manufacturing challenges.
-
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
FEATURED NEWS HEADLINES
- CN Bio And Pharmaron Establish Long-Term Strategic Partnership To Develop OOC Technologies On A Global R&D Platform
- Charles River Leverages Advanced Technology To Expedite Oncology Drug Discovery And Development
- TNF Pharmaceuticals And Renova Health Utilize AI To Accelerate Drug Development
- Argonne Leverages AI And Supercomputing To Revolutionize Cancer Research
- CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License From Chinese NMPA
- UT Health San Antonio-Led Discovery Means IV Medication Could Be Taken Orally For Range Of Cancer, Alzheimer's Treatments
- Viatris Files Supplemental New Drug Applications To Japan's Ministry Of Health, Labor And Welfare For The Approval Of EFFEXOR® For The Treatment Of Generalized Anxiety Disorder
- Kelun-Biotech's Novel ADC Drug SKB518 Has Been Granted The Clearance Of IND From The United States Food And Drug Administration (FDA)
- Redwire Expands In-Space Drug Development Program, Launches New PIL-BOX Technology And Cancer-Detection Experiment
- Zai Lab Announces Acceptance Of Supplemental New Drug Application For Repotrectinib For Patients With NTRK-Positive Solid Tumors
ARCHIVED NEWSLETTER
- 04.22.25 -- How To Approach Tech Transfers And Sponsored Life Sciences Research In AI
- 04.18.25 -- Struggling With CDMO Fit, Capacity, Or Delays? Let's Solve These Challenges Together!
- 04.17.25 -- Struggling With CDMO Fit, Capacity, Or Delays? Let's Solve These Challenges Together!
- 04.15.25 -- Applying AI To Identify Synergistic Drug Combinations For Cancer Treatment
- 04.08.25 -- Mesenchymal Stem Cells Hold The Key To Treating Degenerative Conditions